Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Interest & Investment Income: 2010-2024

Historic Interest & Investment Income for Fortress Biotech (FBIO) over the last 15 years, with Dec 2024 value amounting to $2.7 million.

  • Fortress Biotech's Interest & Investment Income rose 24.96% to $736,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year decrease of 17.08%. This contributed to the annual value of $2.7 million for FY2024, which is 10.66% down from last year.
  • Per Fortress Biotech's latest filing, its Interest & Investment Income stood at $2.7 million for FY2024, which was down 10.66% from $3.0 million recorded in FY2023.
  • In the past 5 years, Fortress Biotech's Interest & Investment Income ranged from a high of $3.0 million in FY2023 and a low of $649,000 during FY2021.
  • Its 3-year average for Interest & Investment Income is $2.4 million, with a median of $2.7 million in 2024.
  • Per our database at Business Quant, Fortress Biotech's Interest & Investment Income slumped by 57.25% in 2021 and then surged by 115.41% in 2022.
  • Yearly analysis of 5 years shows Fortress Biotech's Interest & Investment Income stood at $1.5 million in 2020, then tumbled by 57.25% to $649,000 in 2021, then surged by 115.41% to $1.4 million in 2022, then skyrocketed by 114.81% to $3.0 million in 2023, then declined by 10.66% to $2.7 million in 2024.